Loading, please wait...
This series of presentations will include topics on Medication Assisted Treatment (MAT) such as general understanding of opioid use disorder (OUD), substance use disorders (SUD), FDA approved treatments for OUD, benets of using MAT and recovery services for OUD, neurobiology of addiction and roles of genetics and environment in addiction, initial and periodic patient assessment, dening and choosing the appropriate pharmacological strategy for OUD treatment, safety concerns of drug interactions, informed consent procedures for MAT/OUD, addressing overdose, co-occurring disorders pain management, treating OUD in pregnant women, and the use of telemedicine for MAT.
Register here at the SIUMED (co-sponsor) site (search for the programs by date).
If you do not already have an account on this site, create one and provide your CPE Monitor number and (MMDD) required for credit transmission.
Zoom links for the course:
https://zoom.us/j/95579223494?pwd=blcwVUt0cXo2OFYvYU1yWkZvb09lZz09
Meeting ID: 955 7922 3494 Passcode: 488805
Date: May 5, 2021 07:00 AM - 08:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on May 05, 2021 06:00 AM
Activity Type
- Application
Target Audience(s)
- Pharmacists
- Nurses
- Physicians
- Clinical Psychologists
Accreditation(s)
Disclosure Policy
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict. The existence of relationships does not necessarily imply bias or lessen the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence. The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers. The relevant commercial financial relationships or affiliations must have occured over the past 12 months.
|
||
|
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of completing the activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity. Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
|
|
Co-Sponsor(s)
SIUMED Continuing Education, SHIF, Shawnee Health Services
Registration closes on May 05, 2021
at 06:00 AM
Registration closes on May 05, 2021
at 06:00 AM
Registration Closed
Registration Closed
There is a lack of knowledge in the medical profession on best practices for MOUD/MAT and the effectiveness of MAT in treating opiate use disorders. There is also a need for better access to MAT services in southern Illinois. Case presentations of patients being treated for an opiate use disorder through MAT are not well known/demonstrated. Therefore, there is a lack of resources/examples for providers to examine for best practices for MOUD/MAT.
Each case presentation will provide support and technical assistance for MAT providers to increase competency and comfort level in working in addiction medicine, specifically with opioid use disorder.
https://zoom.us/j/95579223494?pwd=blcwVUt0cXo2OFYvYU1yWkZvb09lZz09
Meeting ID: 955 7922 3494 Passcode: 488805
Objectives
- Identify addiction medicine best practices
- Interpret latest evidence-based opioid use disorder treatment.
Speaker(s)/Author(s)
|
Aaron Newcomb, D.O.
Brief Bio : Dr. Newcomb is a family medicine physician in a FQHC. |
|
Jeffrey W. Ripperda, M.D.
|
Activity Number
0480-9999-21-006-L08-P
Date:
05/05/21
Time:
07:00 AM - 08:00 AM
CE Hours
1.00
Registration Closed